Suppr超能文献

非胰岛素依赖型糖尿病中的微量白蛋白尿

Microalbuminuria in non-insulin-dependent diabetes.

作者信息

Mogensen C E, Damsgaard E M, Frøland A, Nielsen S, de Fine Olivarius N, Schmitz A

机构信息

Medical Department M, Diabetes and Endocrinology, Kommunehospital, Aarhus, Denmark.

出版信息

Clin Nephrol. 1992;38 Suppl 1:S28-39.

PMID:1295705
Abstract

According to international consensus, microalbuminuria is defined as an elevated urinary albumin excretion rate (UAER) of 20-200 micrograms/min, which is below the proteinuric range. Nephropathy is a major complication in IDDM, seen in about 30% of patients after many years of diabetes. Increasing microalbuminuria is an excellent marker of subsequent nephropathy in these patients. End-stage diabetic nephropathy is also important in NIDDM, but in most Western countries this serious complication eventually develops in only 5 to 10% of cases, whereas the majority of patients die before this from cardiovascular disease. In completely healthy individuals there is no clear correlation between age and UAER, at least up to about 70 years of age. The mean excretion rate is around 5 micrograms/min, with a considerable range, but excretion only rarely exceeds 15 micrograms/min. In population studies among middle-aged and elderly individuals, higher values are seen. In newly diagnosed NIDDM about 40% of patients show an excretion rate above 15-20 micrograms/min. There is a significant but not precise correlation between albumin excretion rate and glycemic control, and usually UAER is reduced by standard antidiabetic treatment. In a considerable number of patients, high values cannot be reduced. In the course of NIDDM about 20-30% of patients show microalbuminuria. In patients with known diabetes, microalbuminuria is related not only to subsequent diabetic proteinuria, but even more strongly to early death, mainly from cardiovascular disease. Even slight microalbuminuria (15-40 mg/l in early morning urines) is clearly associated with increased mortality. In subjects with newly detected elevated blood glucose (by screening) microalbuminuria also predicts early mortality. The mechanisms are not established, but several arteriosclerosis-related risk factors are seen more frequently in patients with microalbuminuria, e.g. lipid abnormalities, elevated systolic blood pressure (BP), hemostatic measures, as well other markers of cardiovascular disease. Usually there is a significant but not precise correlation between BP and UAER in groups of patients throughout the course of diabetes. New studies document that also in the elderly background population microalbuminuria is a significant risk factor for early death, maybe even stronger than the established risk markers, which thus may be confounded with the presence of microalbuminuria.

摘要

根据国际共识,微量白蛋白尿的定义为尿白蛋白排泄率(UAER)升高至20 - 200微克/分钟,这低于蛋白尿范围。肾病是胰岛素依赖型糖尿病(IDDM)的主要并发症,在患糖尿病多年的患者中约30%会出现。微量白蛋白尿增加是这些患者后续发生肾病的一个良好指标。终末期糖尿病肾病在非胰岛素依赖型糖尿病(NIDDM)中也很重要,但在大多数西方国家,这种严重并发症最终仅在5%至10%的病例中发生,而大多数患者在此之前死于心血管疾病。在完全健康的个体中,年龄与UAER之间没有明显的相关性,至少在70岁左右之前是这样。平均排泄率约为5微克/分钟,范围相当大,但排泄量很少超过15微克/分钟。在中年和老年人群的研究中,会出现较高的值。在新诊断的NIDDM患者中,约40%的患者排泄率高于15 - 20微克/分钟。白蛋白排泄率与血糖控制之间存在显著但不精确的相关性,通常标准抗糖尿病治疗可使UAER降低。在相当数量的患者中,高值无法降低。在NIDDM病程中,约20% - 30%的患者会出现微量白蛋白尿。在已知患有糖尿病的患者中,微量白蛋白尿不仅与后续的糖尿病蛋白尿有关,甚至更强烈地与早期死亡有关,主要是心血管疾病导致的死亡。即使是轻微的微量白蛋白尿(晨尿中为15 - 40毫克/升)也明显与死亡率增加有关。在新检测出血糖升高(通过筛查)的受试者中,微量白蛋白尿也可预测早期死亡率。其机制尚未明确,但在微量白蛋白尿患者中更频繁地出现几种与动脉硬化相关的危险因素,例如脂质异常、收缩压(BP)升高、止血指标以及其他心血管疾病标志物。在糖尿病患者群体的整个病程中,BP与UAER之间通常存在显著但不精确的相关性。新的研究表明,在老年背景人群中,微量白蛋白尿也是早期死亡的一个重要危险因素,甚至可能比已确定的风险标志物更强,因此可能与微量白蛋白尿的存在相互混淆。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验